Asthma Device Market Share, Production, Revenue, Growth & Trend Forecast, 2018-2023

Market Analysis 

The global asthma devices market is likely to grow at a 4.3% CAGR between 2017- 2023, according to the recent Market Research Future (MRFR) report. Asthma inhalers, simply put, are medical devices that deliver medication to the body through the lungs, thus treating chronic obstructive pulmonary disease and asthma. 

Various factors are adding to the global asthma devices market share. These factors, as per the new MRFR report, include rapid industrialization & urbanization, rising cases of asthma, increasing healthcare expenditure, growing awareness, increasing expenditure on research and development activities, economic development, increasing disposable income, and technological advances. Industrialization and urbanization have increased air pollution due to which the majority of the people are having respiratory problems. 

On the contrary, lack of favorable reimbursement policies, low per capita income, & long treatment procedures are factors that may limit the asthma devices market growth over the forecast period. 

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global asthma devices market based on end users, technology, and type. 

By type, the global asthma devices market is segmented into nebulizers, inhalers, and others. The inhalers segment is again segmented into dry powder inhalers and metered-dose inhalers. The metered-dose inhalers are again segmented into metered-dose inhalers with a spacer, breath-activated pressurized metered-dose inhalers, standard pressurized metered-dose inhalers, and others. The nebulizers segment is again segmented into mesh nebulizers, ultrasonic nebulizers, compressor nebulizers, and others. 

By technology, the global asthma devices market is segmented into digitally operated inhaler devices, manually operated inhaler devices, and others. 

By end users, the global asthma devices market is segmented into retail pharmacies, clinics, and hospitals, and others. 

Key Players 

Eminent players profiled in the global asthma devices market report include Koninklijke Philips N.V. (Europe), Boehringer Ingelheim GmbH (Europe), Baxter. (U.S.), AstraZeneca (Europe), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), Aristopharma Ltd. (Asia Pacific), 3M (U.S.), Merck & Co., Inc. (U.S.), and GlaxoSmithKline plc. (Europe). Industry players have incorporated strategies such as mergers, acquisitions, joint ventures and collaborations, new product development and new product launches, research and development, geographic expansions, and contracts to create a niche in the market. 

Article source: https://article-realm.com/article/Sports-Recreation/12585-Asthma-Device-Market-Share-Production-Revenue-Growth-and-Trend-Forecast-2018-2023.html